Gene · 917
Papers1,874
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,874
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Insufficient epitope-specific T cell clones are responsible for impaired cellular immunity to inactivated SARS-CoV-2 vaccine in older adults. | Nat Aging | 2023 | 37117789 | PubTator, text mining | PubMed |
| A novel integrated approach to predicting cancer immunotherapy efficacy. | Oncogene | 2023 | 37100920 | PubTator, text mining | PubMed |
| Programmed cell death-1 receptor-mediated regulation of Tbet+NK1.1- innate lymphoid cells within the tumor microenvironment. | Proc Natl Acad Sci U S A | 2023 | 37098069 | PubTator, text mining | PubMed |
| IL-1β Is an Androgen-Responsive Target in Macrophages for Immunotherapy of Prostate Cancer. | Adv Sci (Weinh) | 2023 | 37092583 | PubTator, text mining | PubMed |
| Modeling cross-talk of RNA modification enzymes reveals tumor microenvironment-associated clinical significance and immunotherapy prediction in hepatobiliary malignancy. | MedComm (2020) | 2023 | 37090117 | PubTator, text mining | PubMed |
| Tumor and immune remodeling following radiotherapy in human renal cell carcinoma. | J Immunother Cancer | 2023 | 37080610 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals transcriptional profiles of monocytes in HBV-infected pregnant women during mid-pregnancy. | J Cell Mol Med | 2023 | 37078407 | PubTator, text mining | PubMed |
| The Chromatin Landscape of Pathogenic Transcriptional Cell States in Rheumatoid Arthritis. | bioRxiv | 2023 | 37066336 | PubTator, text mining | PubMed |
| Transcriptomic analysis reveals shared gene signatures and molecular mechanisms between obesity and periodontitis. | Front Immunol | 2023 | 37063877 | PubTator, text mining | PubMed |
| Deep characterization of human γδ T cell subsets defines shared and lineage-specific traits. | Front Immunol | 2023 | 37063856 | PubTator, text mining | PubMed |
| Stalled oligodendrocyte differentiation in IDH-mutant gliomas. | Genome Med | 2023 | 37055795 | PubTator, text mining | PubMed |
| Single-Cell Sequencing-Based Validation of T Cell-Associated Diagnostic Model Genes and Drug Response in Crohn's Disease. | Int J Mol Sci | 2023 | 37047025 | PubTator, text mining | PubMed |
| Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab. | Nat Cancer | 2023 | 37038005 | PubTator, text mining | PubMed |
| Identification of cancer-associated fibroblasts subtypes in prostate cancer. | Front Immunol | 2023 | 37033924 | PubTator, text mining | PubMed |
| Molecular subtypes predict therapeutic responses and identifying and validating diagnostic signatures based on machine learning in chronic myeloid leukemia. | Cancer Cell Int | 2023 | 37024911 | PubTator, text mining | PubMed |
| Analyses of thymocyte commitment to regulatory T cell lineage in thymus of healthy subjects and patients with 22q11.2 deletion syndrome. | Front Immunol | 2023 | 37006241 | PubTator, text mining | PubMed |
| Targeting protein tyrosine phosphatases for CDK6-induced immunotherapy resistance. | Cell Rep | 2023 | 37000627 | PubTator, text mining | PubMed |
| A single-cell atlas reveals shared and distinct immune responses and metabolic profiles in SARS-CoV-2 and HIV-1 infections. | Front Genet | 2023 | 36992700 | PubTator, text mining | PubMed |
| Diagnostic markers and potential therapeutic agents for Sjögren's syndrome screened through multiple machine learning and molecular docking. | Clin Exp Immunol | 2023 | 36988140 | PubTator, text mining | PubMed |
| Development and Validation of a Prognostic Risk Model Based on Nature Killer Cells for Serous Ovarian Cancer. | J Pers Med | 2023 | 36983585 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/917/papers?page=15